首页> 外文期刊>Mini-Reviews in Medicinal Chemistry >The Development of Inhibitors of Heparanase, a Key Enzyme Involved in Tumour Metastasis, Angiogenesis and Inflammation
【24h】

The Development of Inhibitors of Heparanase, a Key Enzyme Involved in Tumour Metastasis, Angiogenesis and Inflammation

机译:肝素酶抑制剂的发展,肝素酶是一种参与肿瘤转移,血管生成和炎症的关键酶。

获取原文
获取原文并翻译 | 示例
       

摘要

Heparanase is an endo-β-glucuronidase that degrades the glycosaminoglycan heparan sulfate, a major component of the extracellular matrix and basement membranes, and has been implicated in such processes as inflammation, angiogenesis and metastasis. The identification of inhibitors of heparanase is an attractive approach towards developing new therapeutics for metastatic tumours and chronic inflammatory diseases. This review focuses on heparanase inhibitors that have been isolated or synthesised to date. More recent developments in the understanding of heparanase structure and function that may ultimately aid in the future design of inhibitors with improved potency and specificity, are also discussed.
机译:乙酰肝素酶是一种内源性β-葡糖醛酸苷酸酶,其降解糖胺聚糖硫酸乙酰肝素,这是细胞外基质和基底膜的主要成分,并且与炎症,血管生成和转移等过程有关。肝素酶抑制剂的鉴定是开发针对转移性肿瘤和慢性炎性疾病的新疗法的有吸引力的方法。这篇综述集中于迄今已分离或合成的乙酰肝素酶抑制剂。还讨论了对乙酰肝素酶结构和功能的了解的最新进展,这些进展可能最终有助于将来设计具有增强效价和特异性的抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号